Skip to main content
Clinical Trials/NL-OMON40339
NL-OMON40339
Completed
Not Applicable

Intraoperative detection of tumor tissue in peritoneal carcinomatosis of colorectal origin using a VEGF-targeted Optical Fluorescent Imaging Tracer. A single centre Pilot study (HI-LIGHT study NL45588) - VEGF-Targeted NIR imaging in Peritoneal Carcinomatosis

niversitair Medisch Centrum Groningen0 sites10 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age \>\= 18 years.
  • Patients with histopathological proven peritoneal carcinomatosis from colorectal origin who are scheduled to the HIPEC procedure
  • Patient is considered to be mentally and physically fit for the HIPEC procedure as judged by the responsible physician
  • WHO performance score 0\-2
  • Signed written informed consent.

Exclusion Criteria

  • Concomitant malignancies, except for adequately treated basocellular carcinoma of the skin or in situ carcinoma of the cervix uteri. Subjects with prior malignancies must be disease\-free for at least 5 years.
  • Distance metastasis (liver / lungs)
  • Medical or psychiatric conditions that compromise the patient\*s ability to give informed consent.
  • Concurrent uncontrolled medical conditions.
  • Pregnancy or breast feeding.
  • Clinically significant (i.e. active) cardiac disease (e.g. congestive heart failure, symptomatic coronary artery disease and cardiac dysrhythmia, e.g. atrial fibrillation, even if controlled with medication) or myocardial infarction within the past 12 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials